Cofoe Medical Technology (01187): Blood glucose monitoring products have obtained EU CE certification.
Kebu Medical (01187) announced that recently, two blood glucose monitoring products from Kebu Medical Technology Co., Ltd. (hereinafter referred to as the "Company") have obtained EU CE certification and can be sold in EU countries and countries that recognize EU CE certification.
Cofoe Medical Technology (01187) announces that recently, two blood glucose monitoring products of Cofoe Medical Technology Technology Co., Ltd. (hereinafter referred to as the "Company") have obtained EU CE certification and can be sold in EU countries and countries recognized with EU CE certification.
The blood glucose monitoring system has obtained EU CE certification this time, and the company's other products have also obtained market access qualifications in many overseas markets, further improving the company's product matrix at home and abroad, laying a solid foundation for the globalization of business expansion. The company will continue to promote the sales of the above products to create greater value for shareholders.
Related Articles
ABC MULTIACTIVE (08131) successfully completed the placement of a total of 120 million shares, raising approximately HKD 11.5 million.
On June 30, ANTON OILFIELD (03337) spent 4.2343 million Hong Kong dollars to repurchase 5.068 million shares.
PUBLIC FIN HOLD (00626) will distribute a special dividend of 2 Hong Kong cents per share on August 5th.
ABC MULTIACTIVE (08131) successfully completed the placement of a total of 120 million shares, raising approximately HKD 11.5 million.
On June 30, ANTON OILFIELD (03337) spent 4.2343 million Hong Kong dollars to repurchase 5.068 million shares.
PUBLIC FIN HOLD (00626) will distribute a special dividend of 2 Hong Kong cents per share on August 5th.
RECOMMEND
